Journals / Nöropsikiyatri Arşivi / 2016 / Cilt: 53 - Sayı: 1

Kriptojenik İnmede Patent Foramen Ovalenin Rolü

The Role of Patent Foramen Ovale in Cryptogenic Stroke

Pages
63–66
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We want to emphasize the importance of TEE in identifying potential cardioembolic sources not only in young but also in all ischemic stroke patients with unknown etiology; we also discuss the controversial management options of PFO

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Almost one-third of ischemic strokes has an unknown etiology and are classified as cryptogenic stroke.
📊
Key Findings & Data:Paradoxical embolism because of a patent foramen ovale (PFO) is detected in 40%-50% of these patients.
💡
Conclusion & Impact:We want to emphasize the importance of TEE in identifying potential cardioembolic sources not only in young but also in all ischemic stroke patients with unknown etiology; we also discuss the controversial management options of PFO
🔬Design:Research Article
📍Scope:2011-2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: Almost one-third of ischemic strokes has an unknown etiology and are classified as cryptogenic stroke. Paradoxical embolism because of a patent foramen ovale (PFO) is detected in 40%-50% of these patients. Recently, PFO has been reported as a risk factor for patients of all age groups.Methods: In this study, 1080 ischemic stroke patients admitted to our clinic (2011-2013) were retrospectively evaluated. Age, sex, risk factors, complete blood count, vasculitis, biochemical and hypercoagulability tests, magnetic resonance imaging, magnetic resonance angiography, transthoracic echocardiography, transeosophageal echocardiography (TEE) findings, and therapeutic approaches were evaluated. Results: The age range of the participants (seven male and four female patients) was 20-60 years (mean=43.09±11.13 years). Hemiparesis (n=10), diplopia (n=2), hemianopsia (n=2), and dysarthria (n=2) were the main findings of the neurological examinations. Patient medical history revealed hypertension (n=3), asthma (n=1), deep venous thrombosis (n=1), and smoking (n=4). Diffusion-weighted imaging showed middle cerebral artery (n=8) and posterior cerebral artery (n=3) infarctions. In one case, symptomatic severe carotid stenosis was detected. In eight cases, TEE showed PFO without any other abnormalities, but PFO was associated with atrial septal aneurysm in two cases, and in one case it was associated with ventricular hypokinesia and pulmonary arterial hypertension. Antiplatelet therapy was applied to nine patients and percutaneous PFO closure operation to two patients. In a 2-year follow-up, no recurrent ischemic stroke was recorded. Conclusion: PFO, especially in terms of the etiology of cryptogenic stroke in young patients, should not be underestimated. We want to emphasize the importance of TEE in identifying potential cardioembolic sources not only in young but also in all ischemic stroke patients with unknown etiology; we also discuss the controversial management options of PFO

Özet

Amaç: İskemik inmelerin yaklaşık üçte birinde etyolojik sebep bulunamamakta ve bunlar kriptojenik inme olarak sınıflandırılmaktadır. Patent foramen ovaleye (PFO) bağlı paradoksal emboli bu hastalarda %40-50 oranında tespit edilmektedir. Son zamanlarda, PFO tüm yaş gruplarında bir risk faktörü olarak bildirilmektedir Yöntem: Bu çalışmada, kliniğimizde 2011-2013 yıllarında takip edilen 1080 iskemik inme hastası retrospektif olarak değerlendirildi. Yaş, cinsi-yet, risk faktörleri, hemogram, biyokimya, vaskülit ve hiperkoagülobilite testleri, manyetik rezonans görüntüleme, manyetik rezonans anjiyografi, transtorasik ekokardiyografi ve transözofajial ekokardiyografi (TEE) bul-guları ve tedavi yaklaşımları değerlendirildi. Bulgular: Hastaların yaşları 20-60 yıl arasında olup (ortala-ma=43,09±11,13 yıl), 7'si erkek, 4'ü kadındı. Nörolojik muayenelerinde hemiparezi (n=10), diplopi (n=2), hemianopsi (n=2) ve dizartri (n=2) mevcuttu. Özgeçmişlerinde hipertansiyon (n=3), astım (n=1), derin ven trombozu (n=1) ve sigara (n=4) vardı. Difüzyon ağırlıklı görüntüleme-de orta serebral arter (n=8) ve posterior serebral arter (n=3) infarktı görüldü. Bir hastada semptomatik ciddi karotis darlığı tespit edildi. Sekiz hastada, TEE'de başka anormallik olmaksızın PFO mevcutken, 2 olguda, atriyal septal anevrizma ve 1 olguda ise PFO, ventriküler hipokinezi ve pulmoner arteriyel hipertansiyon ile birlikteydi. Dokuz hastaya antipla-telet tedavi, 2 hastaya perkütan PFO kapatma işlemi uygulandı. İki yıllık takiplerinde, tekrarlayan iskemik inme gerçekleşmedi. Sonuç: PFO, özellikle genç hastalarda kriptojenik inmenin etiyolojisinde göz ardı edilmemelidir. Bu çalışmada tüm yaş gruplarında nedeni bilinme-yen iskemik inme hastalarında potansiyel kardiyoembolik nedenlerin be-lirlenmesinde TEE'nin önemini vurgulamak ve ayrıca PFO'nun tartışmalı tedavi seçeneklerinden söz etmek istedik

🔖

Cite This Article

ŞENADIM, S., BOZKURT, D., ÇABALAR, M., BAJRAMI, A., YAYLA, V. A. (2016). Kriptojenik İnmede Patent Foramen Ovalenin Rolü. Nöropsikiyatri Arşivi, Cilt: 53 - Sayı: 1, 63–66. https://ajindex.com/articles/292826

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, Wolf PA. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989; 25:382-390. [CrossRef] Di Tullio M, Sacco R, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992; 117:461-465. [CrossRef] Cohnheim J. Trombose und Embolie In: Vorlesung uber Allgemeine Patholo- gie. Berlin, Germany: Hirschwald, 1877; 134. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984; 59:17-20. [CrossRef] Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a me- ta-analysis of case-control studies. Neurology 2000; 55:1172-1179. [CrossRef] Medina A, de Lezo JS, Caballero E, Ortega JR. Platypnea-orthodeoxia due to aortic elongation. Circulation 2001; 104:741. [CrossRef] Torti SR, Billinger M, Schwerzmann M, Vogel R, Zbinden R, Windecker S, Seiler C. Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale. Eur Heart J 2004; 25:1014-1020. [CrossRef] Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neu- rology 1999; 52:1622-1625. [CrossRef] Domitrz I, Mieszkowski J, Kwiecinski H. The prevelance of patent foramen ovale in patients with migraine. Neural Neurochir Pol 2004; 38:89-92.
  2. Meissner I, Whisnant JP, Khandheria BK, Spittell PC, O'Fallon WM, Pascoe RD, Enriquez-Sarano M, Seward JB, Covalt JL, Sicks JD, Wiebers DO. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiogra- phy and carotid ultrasonography: the SPARC study: Stroke Prevention: Asses- ment of Risk in a Community. Mayo Clin Proc 1999; 74:862-869. [CrossRef] Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007; 357:2262- 2268. [CrossRef] Alzamora MT, Sorribes M, Heras A, Vila N, Vicheto M, Forés R, Sánchez-Ojan- guren J, Sancho A; "ISISCOG Study Group", Pera G. Ischemic stroke incidence in Santa Coloma de Gramenet (ISISCOG), Spain. A community-based study. BMC Neurol 2008; 8:5. Kraywinkel K, Jauss M, Diener HC, Weimar C. Patent foramen ovale, atrial septum aneurysm, and stroke. An examination of the status of recent evi- dence. Nervenarzt 2005; 76:935-942. [CrossRef] Mattle HP, Meier